More Business Wire
View Older Stories View Newer Stories-
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
-
Locus Robotics and Radial Surpass 25 Million Picks Milestone as Demand for Scalable Fulfillment Intensifies
-
Manhattan Associates Announces Appointment of Katie Foote as Chief Marketing Officer
-
NantWorks and ImmunityBio Announce Inaugural U.S.-Saudi Biotech Alliance Summit to Advance Immunotherapy 2.0 and Global Health Security
-
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
-
Global Partners Announces Cash Distribution on Series B Preferred Units
-
CBRE Group, Inc. Announces Details of Conference Call and Webcast for Fourth Quarter and Full-Year 2025 Financial Results
-
Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025
-
Bloomreach Announces Loomi Connect, Bringing Your Brand’s Search Intelligence to the OpenAI Marketplace
-
ALT5 Sigma Corporation Reports Q3 2025 Financial Results and Significant Milestones
-
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
-
LPA Secures Anchor Tenant and Breaks Ground on Fully Pre-Leased Building 400 at Parque Logístico Callao in Peru
-
BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park
-
Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors
-
Aspen Power Secures $200 Million Strategic Capital Commitment from Deutsche Bank
-
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
-
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
-
Mitek Recognized as a Leader in Fraud and Identity Verification by Datos Insights
-
Dispatch Bio and CARsgen Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
-
Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth of at least 17% Year over Year
-
Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome
-
Fairbanks Morse Defense Expands Robotic Welding Capabilities to Strengthen Fleet Readiness and Reduce Maintenance Downtime
-
Junevity Announces First Peer-Reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging
-
32nd Annual Venture Capital & Private Equity Conference at Harvard Business School Announces Speakers and Agenda
-
National CineMedia Launches 2026 US Young Lions Competition
-
Adam Yale Joins First Manhattan as Portfolio Manager, Based in Omaha
-
Miro Launches Collaborative AI Workflows to Transform How Teams Work and Accelerate Innovation
-
CQL Launches POS360° to Unify Online & In-Store Data between Shopify POS and Bloomreach
-
Riskified Analysis Reveals 1 in 4 Refund Dollars Is Abusive; Introduces "Dynamic Returns," a New Policy Protect Feature, to Safeguard Revenue While Increasing Customer Satisfaction
-
Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation
-
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
-
Amphenol Completes Acquisition of CCS Business From CommScope
-
Sole Source Capital Acquires Brite, a Cybersecurity & Managed Services Provider
-
Tamboran Appoints Mr. Todd Abbott as Chief Executive Officer
-
Atlantic Alumina Announces $450 Million Strategic Partnership with United States Government to Secure U.S. Alumina Production and Build America’s First Large Scale Primary Gallium Production Circuit
-
Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth
-
Pagaya to Participate in Upcoming Investor Conferences and Events
-
HighPost Capital Promotes David Weston to Senior Managing Director
-
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
-
The ONE Group Reports Preliminary Fourth Quarter and Full Year 2025 Sales Results
-
PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
-
Hummingbird Diagnostics Names Vincent Lozada Chief Executive Officer
-
American Eagle Outfitters Reports Record Holiday Sales
-
Curi Bio Launches Asia-Pacific Hub, Delivering Greater Support to its Growing APAC Business
-
Sleep Number Introduces ComfortMode™ Mattress: Premium Comfort at an Affordable Price
-
o9 Expands Its Next-Generation Category Management Solution for Grocery Retail
-
Offerpad Solutions Inc. Announces Pricing of $18 Million Registered Direct Offering
-
Dispatch Bio Announces FDA Clearance of IND Application for DISP-10, a First-in-Class Immunotherapy Treatment, in Solid Tumors
-
Manas AI Secures Strategic Advantage through Unique Deep Integration with Schrödinger’s Physics + AI Discovery Platform
-
U.S. FDA Grants RMAT Designation to ECT204, an ARTEMIS® CAR (AbTCR) T-Cell Therapy for Advanced Hepatocellular Carcinoma
